2011
DOI: 10.1155/2011/212516
|View full text |Cite
|
Sign up to set email alerts
|

Malignant Cerebral Edema following CT Myelogram Using Isovue-M 300 Intrathecal Nonionic Water-Soluble Contrast: A Case Report

Abstract: Lumbar myelogram utilizing nonionic contrast is a commonly performed procedure to identify spinal pathology. Complication rates are low. Cerebral edema has been shown to occur following intrathecal injection of ionic contrast; however, no current literature has documented this complication relating to the ubiquitously used nonionic contrast medium. We report a case of a patient who developed malignant cerebral edema following a lumbar myelogram with Isovue-M 300 nonionic water-soluble intrathecal contrast. We … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
1
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 59 publications
(60 reference statements)
1
1
0
Order By: Relevance
“…3 However, even lowosmolar, nonionic agents have been shown to potentially cause malignant cerebral edema and transient encephalopathy, presumably via disruptions in the bloodebrain barrier that might accompany increasing age, hypertension, and cerebrovascular ischemia, among other factors. 4,5 Parietooccipital areas of the brain are thought to be more sensitive to this effect, which would be consistent with this case. [6][7][8] Awareness of this potential adverse reaction to nonionic, low-osmolar agents after intrathecal use in patients at risk, such as the elderly or those with mildly impaired renal function, can help internists and hospitalists optimize high value care.…”
supporting
confidence: 83%
“…3 However, even lowosmolar, nonionic agents have been shown to potentially cause malignant cerebral edema and transient encephalopathy, presumably via disruptions in the bloodebrain barrier that might accompany increasing age, hypertension, and cerebrovascular ischemia, among other factors. 4,5 Parietooccipital areas of the brain are thought to be more sensitive to this effect, which would be consistent with this case. [6][7][8] Awareness of this potential adverse reaction to nonionic, low-osmolar agents after intrathecal use in patients at risk, such as the elderly or those with mildly impaired renal function, can help internists and hospitalists optimize high value care.…”
supporting
confidence: 83%
“…In a retrospective analysis, Klein et al report a risk of seizures in nonepileptic individuals and risk of status epilepticus in patients with epilepsy who have received Iopamidol myelography [ 13 ]. Kelley et al described a case of cerebral edema in a 50-year-old female patient who presented with increased somnolence, headache, and visual changes a day following CT myelogram with Iopamidol [ 14 ]. Other reported cases have also described similar complications.…”
Section: Discussionmentioning
confidence: 99%